Project Grant R21DE033851

Award Date 9/19/24
Completion Date 8/31/26
Dollars Obligated $551K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to establish a novel zebrafish model of syndromic craniosynostosis. The $313,000 award to Emory University will enable comprehensive phenotypic, mechanistic, and genetic analyses of the craniosynostosis mutant zebrafish to better understand the underlying pathological mechanisms. The research aims to identify...
This $453,750 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to investigate the genetic and cellular mechanisms underlying craniosynostosis, a common craniofacial birth defect. The research team at Boston University Medical Campus will use a zebrafish model to study the role of the ERF transcription factor in normal skull development and how its reduction...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $606,296 project grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the University of Missouri System on May 1, 2025. The grant supports a 5-year research project to develop state-of-the-art, three-dimensional growth models of the craniofacial complex using advanced cone-beam computed tomography (CBCT) imaging. The goal is to create new growth standards that incorporate the three-dimensional nature of the...
This Project Grant award of $804,478 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to generate a single-cell atlas of human craniofacial development and use evolutionary analysis to identify enhancers critical for midface development. The goal is to improve understanding of the genetic basis of midface defects, including clefts of the lip and palate, which can substantially...
This National Institute of Dental and Craniofacial Research (NIDCR) Project Grant award under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $320,053 to the University of Southern California (USC) to conduct comprehensive research on the craniofacial skeleton and connective tissue development. The 8-year project will utilize advanced techniques in spatial transcriptomics and mouse genetics to identify genes and pathways regulating the assembly of the craniofacial...
This Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Department of Health and Human Services, will fund research into the genetic basis of human skeletal facial morphology through July 2025. Provided under the Oral Diseases and Disorders Research program (CFDA 93.121), the $936,510 in funding will support two key aims. First, the awardee will enhance current mesh landmarking procedures for craniofacial bone by developing a dense quasi-landmark...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Program (CFDA 93.121), provides $1,867,823.00 to Cincinnati Children's Hospital Medical Center to study the genomic and developmental mechanisms underlying Six2-related frontonasal dysplasia, a congenital craniofacial disorder. The research aims to unravel how structural variations in the genome can disrupt the local organization of...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $619,304.36 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research on mapping and predicting the effects of transcription factor dosage on craniofacial morphology and disease. The project aims to develop tools to precisely modulate the dosage of craniofacial transcription factors in...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $302,318 Project Grant under the Oral Diseases and Disorders Research Program (CFDA 93.121) to Rutgers, The State University. The grant will fund research to investigate the effects of skull malformations and intracranial hypertension on the glymphatic and meningeal lymphatic systems in craniosynostosis. Key aims include testing if impaired glymphatic (cerebrospinal fluid) influx and efflux impedes the clearance of...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $646,212 to support research on the role of primary cilia and C2CD3 in craniofacial skeletogenesis. The research aims to determine how mutations in the C2CD3 gene, which cause the human ciliopathy Oral-Facial-Digital Syndrome 14 (OFD14), impact skeletal differentiation, the association between the centriole and actin...

This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $550,810 to Vanderbilt University Medical Center (VUMC) to create the Human Craniosynostosis Atlas (HUCA). HUCA aims to establish a public repository of standardized genomic and neuroimaging data on craniosynostosis, a premature fusion of the cranial sutures affecting approximately 1 in 2,000 infants annually. The project will collect CT, MRI, and whole genome sequencing data from infants with craniosynostosis and their parents, and transfer this data to the existing NIDCR-supported FaceBase 3 biorepository. By creating this comprehensive multi-modal dataset, the project seeks to improve the fundamental understanding and characterization of craniosynostosis, with the goal of enabling clinicians to better predict and optimize treatment outcomes. The award period runs from Sep 19, 2024 to Aug 31, 2026.

Generated 7/15/25, 8:58 AM